// App-Quantinova.ai

522 : Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Researchers

Presenter

  • Danish Memon

Principal Investigators

  • Matthew Hellmann

  • Martin Miller

Medical Centers

  • University of Cambridge, Cambridge, UK

  • AstraZeneca, New York, NY, United States

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Colorectal Cancer

  • Lung Cancer

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved